TornadoVM, an open-source plug-in for OpenJDK and GraalVM that compiles and offloads Java code to accelerators such as GPUs, ...

MiniStudio is a Paris-based AI banner that rolled out in 2024 with just one IP, 'Fuzzlets' which has quietly become a ...

The Phoenix-based developers of an Atari-themed hotel planned on Roosevelt Row are hoping nostalgia and excitement might motivate old-school video game fans to invest in the project. Intersection ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The buyer is a local developer ...

Explore the inner workings of the javax.crypto.Cipher class in Java's cryptography API: understand its provider-based architecture ...

This week, "All I Want for Christmas Is You" takes the record outright, as it posts an unprecedented 20th week on top of the Hot 100. And, given the likelihood of it returning to No. 1 — not just next ...

Mariah Carey’s “All I Want for Christmas Is You” is now the longest-running No. 1 song in U.S. chart history. The 1994 modern Christmas classic has spent a cumulative 20 weeks atop the Billboard Hot ...

Some tout a daily semaglutide pill as a game-changer for weight-loss treatment. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo ...

The carol leads for a 21st week. Plus, Bobby Helms' "Jingle Bell Rock" hits a new No. 2 high. By Gary Trust Mariah Carey‘s “All I Want for Christmas Is You” adds a record-extending 21st week at No. 1 ...

This week's Five Burning Questions looks at the Queen of Christmas re-capturing one of the most hallowed records in Billboard chart history. For over 20 years, Mariah Carey reigned (alongside ...

"All I Want for Christmas Is You" was previously the only holiday song to ever top the 'Billboard' Global 200 chart Jack Irvin has over five years of experience working in digital journalism, and he’s ...

The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk plans to launch the once-daily oral semaglutide in the US in early January ...